Boron Neutron Capture Therapy Using CICS-1 and SPM-011 for Malignant Melanoma and Angiosarcoma

NCT04293289 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Melanoma
Angiosarcoma

Interventions

OTHER: CICS-1 (investigational device),SPM-011(investigational drug)

Sponsor

Cancer Intelligence Care Systems, Inc.

Collaborators

[object Object]